Evotec and Bristol Myers Squibb Extend and Expand Strategic Neurodegeneration Partnership

Evotec SE announced that the Company has extended and expanded its strategic neurodegeneration partnership with Bristol Myers Squibb, originally signed in 2016.

Scroll to Top